Finoriq research workspace
Adaptive Biotechnologies Corp (ADPT) Company Overview
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform. Review ADPT filings, fundamentals, valuation, and ownership on Finoriq.
Company Snapshot
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
- Company
- Adaptive Biotechnologies Corp (ADPT)
- Ticker
- ADPT
- Market Cap
- $3.5B
- Latest Price
- $21.85
- Industry
- Biotech & Pharma
Adaptive Biotechnologies Corp (ADPT) Current Valuation Metrics
Static valuation preview for Adaptive Biotechnologies Corp (ADPT). Market data retrieved 2026-07-08. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 10.9x | Revenue | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | -1.5% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -0.84% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 14.9x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.